SILICON-BASED MOLECULAR SENSORING TECHNOLOGY CO., LTD.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Semiconductor Biomedical Chips, Trace Biomedical Molecular Detection Instruments, Biomedical Chip Contract Development (ODM), Contract Testing Services
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2014
Unified Business No.
24565175
Status
Active
Number of Employees
0
Total Paid-in
Capital
171,897,506 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Silicon-based Molecular Electric Detection (Molsentech) is dedicated to developing "semiconductor biomedical chips" and "trace biomedical molecular detection instruments." Rooted in Taiwan's leading semiconductor industry, the company pursues the goal of making precision testing simpler.
Molsentech was established in 2014. Its core team originates from the Quantum Electronic Device Laboratory of the Institute of Physics, Academia Sinica. The team began research on silicon nanowire field-effect transistors as early as 1997, possessing over 20 years of experience in developing semiconductor biomedical chips, and is the earliest team in Taiwan to conduct research in this field. We possess world-leading experience and technology in semiconductor biomedical chip development, fully mastering cross-disciplinary technologies such as semiconductor chip design and fabrication, biochemical probe molecular surface modification, microfluidic heterogeneous packaging, and automated detector system integration. Our research achievements have been recognized multiple times by top-tier international SCI journals, and the related technologies have also obtained multiple patents in Taiwan and the United States.
Starting from 2024, the government will implement a 10-year science and technology policy with a budget of up to NT$300 billion: the Taiwan Chip-based Industrial Innovation Program (also known as the IC Taiwan Program), which aims to utilize semiconductor chips to drive the upgrading of various industries. The focus of the IC Taiwan Program's implementation in the biomedical and agricultural fields is the development of semiconductor detection chips, which is precisely what Molsentech has been focusing on for a long time. Through this policy, we will amplify our influence across technology, market, and regulatory dimensions.
(The content above was translated by AI.)
Molsentech was established in 2014. Its core team originates from the Quantum Electronic Device Laboratory of the Institute of Physics, Academia Sinica. The team began research on silicon nanowire field-effect transistors as early as 1997, possessing over 20 years of experience in developing semiconductor biomedical chips, and is the earliest team in Taiwan to conduct research in this field. We possess world-leading experience and technology in semiconductor biomedical chip development, fully mastering cross-disciplinary technologies such as semiconductor chip design and fabrication, biochemical probe molecular surface modification, microfluidic heterogeneous packaging, and automated detector system integration. Our research achievements have been recognized multiple times by top-tier international SCI journals, and the related technologies have also obtained multiple patents in Taiwan and the United States.
Starting from 2024, the government will implement a 10-year science and technology policy with a budget of up to NT$300 billion: the Taiwan Chip-based Industrial Innovation Program (also known as the IC Taiwan Program), which aims to utilize semiconductor chips to drive the upgrading of various industries. The focus of the IC Taiwan Program's implementation in the biomedical and agricultural fields is the development of semiconductor detection chips, which is precisely what Molsentech has been focusing on for a long time. Through this policy, we will amplify our influence across technology, market, and regulatory dimensions.
(The content above was translated by AI.)
